drugset / Trial / NCT00004076

PNU 166148 in Treating Patients With Metastatic Solid Tumors

NCT00004076 ↗

Phase 1 Unknown 30 enrolled University of Glasgow
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of PNU 166148 in treating patients who have metastatic solid tumors that have not responded to previous treatment.

Timeline

Start
1999-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject mureletecan Unknown — Intravenous